4-41748377-G-T
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The ENST00000226382.4(PHOX2B):c.234C>A(p.Tyr78Ter) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. Y78Y) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
ENST00000226382.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PHOX2B | NM_003924.4 | c.234C>A | p.Tyr78Ter | stop_gained | 1/3 | ENST00000226382.4 | NP_003915.2 | |
PHOX2B-AS1 | XR_001741671.2 | n.29G>T | non_coding_transcript_exon_variant | 1/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PHOX2B | ENST00000226382.4 | c.234C>A | p.Tyr78Ter | stop_gained | 1/3 | 1 | NM_003924.4 | ENSP00000226382 | P1 | |
PHOX2B-AS1 | ENST00000508038.1 | n.85G>T | non_coding_transcript_exon_variant | 1/5 | 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | May 18, 2020 | The p.Y78* pathogenic mutation (also known as c.234C>A), located in coding exon 1 of the PHOX2B gene, results from a C to A substitution at nucleotide position 234. This changes the amino acid from a tyrosine to a stop codon within coding exon 1. A different nucleotide substitution (c.234C>G), also resulting in in p.Y78*, has been detected two siblings with Hirschsprung disease and respiratory issues; one sibling had several episodes of desaturations while the second sibling was diagnosed with central apnea. Their mother did not have Hirschsprung disease, but reported episodes of possible apneic episodes during sleep and awakening feeling breathless (Lombardo RC et al. Am. J. Med. Genet. A, 2017 Jun;173:1705-1709). This mutation has also been detected in an additional individual with hypopnea, intermittent desaturations, abnormal sleep study, and additional findings (Katwa U. Am. J. Med. Genet. A. 2018 07;176(7):1627-1631). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.